Deenz Psychopathy Spectrum Scale (DPSS)
normative dataset currently contains
1070
participant records collected between
Jun 11, 2026
and
Jul 18, 2026
.
This psychometric dataset currently includes 1070 anonymous participant responses collected through voluntary participation. The observed mean score was 51.12 with a standard deviation of 16.63, indicating moderate score variability within the sampled population. Internal consistency reliability analysis demonstrated good reliability (Cronbach alpha = 0.87). Observed skewness (-0.19) and kurtosis (-0.25) were examined as indicators of distribution quality. The score distribution appeared reasonably balanced and did not suggest substantial departures from normality.
1070
Participants
73
Countries
24
Scale Items
0.87
Reliability
Table 1
Dataset Overview
Assessment
Deenz Psychopathy Spectrum Scale (DPSS)
Research Status
Robust Dataset
Dataset Maturity
95
/100 —
ROBUST
Participants
1070
Countries Represented
73
Items
24
Dimensions
6
Data Collection Period
Jun 11, 2026
–
Jul 18, 2026
Reliability
α =
0.87
Note.
The current Deenz Psychopathy Spectrum Scale (DPSS) dataset contains 1070 participant records collected from 73 countries. Dataset maturity reflects sample size, geographic diversity, and internal consistency reliability.
Table 2
Descriptive Statistics
Statistic
Value
Mean Score
51.12%
Median Score
51
Standard Deviation
16.63
Variance
276.55
Standard Error
0.51
95% CI Lower
50.13
95% CI Upper
52.12
Minimum Score
0%
Maximum Score
90%
Observed Range
90
Note.
M = 51.12, SD = 16.63, Median = 51. The 95% confidence interval ranged from 50.13 to 52.12.
Table 3
Sample Characteristics
Variable
Summary
Participants
N =
1070
Countries
73
Age Information
Available
Gender Information
Available
Note.
Demographic information was collected voluntarily. Participant counts may vary across demographic categories when information was not reported.
Age Distribution
Age Group
Participants
18-24
152
under18
137
prefer_not
125
25-34
68
35-44
43
45-54
21
55plus
9
Gender Distribution
Gender
Participants
Male
328
Female
213
Prefer_not
14
Figure 1
Global Participation
Note.
Participants were represented across 73 countries. The largest contribution originated from BR (33.6% of available geographic records).
Country
Participants
Percent
BR
360
33.6%
US
148
13.8%
IN
140
13.1%
FR
101
9.4%
DE
42
3.9%
ES
35
3.3%
GB
20
1.9%
MX
14
1.3%
AU
12
1.1%
CA
11
1%
NL
10
0.9%
PH
9
0.8%
IT
9
0.8%
CL
9
0.8%
CO
8
0.7%
AE
7
0.7%
IE
7
0.7%
AT
6
0.6%
ID
6
0.6%
SE
5
0.5%
UA
5
0.5%
T1
5
0.5%
DK
4
0.4%
FI
4
0.4%
CN
4
0.4%
BE
4
0.4%
GE
4
0.4%
PT
4
0.4%
CZ
3
0.3%
SV
3
0.3%
MG
3
0.3%
HU
3
0.3%
EC
3
0.3%
SG
3
0.3%
AR
3
0.3%
GR
3
0.3%
SA
2
0.2%
HR
2
0.2%
BA
2
0.2%
VN
2
0.2%
CH
2
0.2%
RU
2
0.2%
DO
2
0.2%
TH
2
0.2%
LT
2
0.2%
PL
2
0.2%
TN
2
0.2%
MA
2
0.2%
VE
2
0.2%
RS
2
0.2%
BO
2
0.2%
CU
2
0.2%
UY
1
0.1%
EG
1
0.1%
SK
1
0.1%
MV
1
0.1%
PA
1
0.1%
ML
1
0.1%
KR
1
0.1%
RO
1
0.1%
JP
1
0.1%
EE
1
0.1%
KE
1
0.1%
PE
1
0.1%
IL
1
0.1%
LK
1
0.1%
PY
1
0.1%
TR
1
0.1%
MM
1
0.1%
MN
1
0.1%
ZA
1
0.1%
NO
1
0.1%
AO
1
0.1%
Table 4
Percentile Norms
Percentile
Score
Interpretation
10th
29%
Very Low
25th
39%
Below Average
50th
51%
Average
75th
63%
Above Average
90th
74%
Elevated
Note.
Percentile values provide preliminary normative benchmarks derived from the current Deenz Psychopathy Spectrum Scale (DPSS) sample.
Figure 2
Score Distribution
Note.
Observed scores ranged from 0% to 90% (M = 51.12, SD = 16.63). Distribution characteristics included skewness (-0.19) and kurtosis (-0.25).
Distribution indices suggested no substantial departures from normality.
Table 5
Reliability Analysis
Metric
Value
Cronbach Alpha
0.87
Reliability Classification
Good
Participants
1070
Items
24
Standard Error
0.51
Note.
Internal consistency was estimated using Cronbach alpha. Reliability estimates are based on the current normative dataset and may change as additional responses are collected.
Item–Total Correlations
Item Analysis Interpretation
Item–total correlations were generally strong across the assessment, indicating that most items contribute effectively to the measurement of the underlying construct.
The analysis identified6
itemsthat may benefit from future review.
Items Recommended for Future Review
Q1
(r = 0.11)
I am able to resolve conflicts in a peaceful manner.
Q2
(r = 0.08)
I am the type of person who tries my best to avoid making threatening language or aggressive statements.
Q19
(r = 0.18)
If I compare myself to others, these comparisons make me feel worse about myself.
Q21
(r = 0.2)
I always maintain my composure and remain calm even in stressful situations.
Q22
(r = 0.08)
I lack the ability to attract and influence others.
Q24
(r = 0.2)
I often lose interest when listening to someone talk about their problems.
The lowest item–total correlation was observed for Q22 ("I lack the ability to attract and influence others."; r = 0.08), indicating comparatively weaker alignment with the overall construct.
Table 7
Dimension Norms
Dimension
Mean
SD
N
Callousness
61.71%
25.89
1070
Manipulation
58.2%
25.93
1070
Impulsivity
54.1%
26.68
1070
Ego
53.81%
18.72
1070
Aggression
45.09%
20.93
1070
Glibness
35.59%
16.69
1070
Note.
Dimension statistics summarize normative performance across the major constructs measured by Deenz Psychopathy Spectrum Scale (DPSS).
Figure 5
Dimension Profile
Note.
The highest observed dimension was Callousness (61.7%), whereas the lowest observed dimension was Glibness (35.6%). The observed difference between dimensions was 26.1 percentage points. Substantial variation was observed between dimensions.
Table 8
Dataset Growth Summary
Metric
Value
Current Participants
1070
Countries
73
Collection Start
Jun 11, 2026
Collection End
Jul 18, 2026
Months Recorded
2
Note.
Growth statistics summarize cumulative participation throughout the observed data collection period.
Normative Data Notice
A total of
1070
participant responses were available for this assessment.
Dimension-level norms were calculated using
1070
valid response records.
Approximately
0
response record(s) were excluded from dimension-level normative calculations due to incomplete response patterns.
Limitations
Normative statistics are derived from voluntary participation and may not represent all populations. Reliability estimates, percentile norms, and dimension statistics should be interpreted in the context of the current sample and may change as additional responses are collected.
Ethical Statement
All records included in this dataset were collected anonymously. No personally identifying information is stored. Data are intended for educational, psychometric, and research purposes.
Recommended Citation
Deenz Psychopathy Spectrum Scale (DPSS). Research Dataset. Retrieved from https://drdeenz.com/psychopathy-spectrum-test/statistics/